1	3 Subjects whose seizures have been controlled for 12 weeks prior to start of the investigational product with a stable maintenance dose of VPA monotherapy 400-1200 mg/d|VPA[140,143]|||400 - 1200mg[156,167]||||12 weeks[51,59]|||1099703|40254|valproate
